Hepcludex Approval: What Bulevirtide Means for Peptide Medicine
Science & Medicine Hepatitis D Entry Inhibitors Bulevirtide Regulatory Science Report The Gatekeeper Peptide: Why Hepcludex Approval Matters Beyond Hepatitis D On May 22, 2026, the FDA approved Hepcludex (bulevirtide) for chronic hepatitis delta — the first U…











